NO2575858T3 - - Google Patents

Info

Publication number
NO2575858T3
NO2575858T3 NO11790534A NO11790534A NO2575858T3 NO 2575858 T3 NO2575858 T3 NO 2575858T3 NO 11790534 A NO11790534 A NO 11790534A NO 11790534 A NO11790534 A NO 11790534A NO 2575858 T3 NO2575858 T3 NO 2575858T3
Authority
NO
Norway
Application number
NO11790534A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2575858T3 publication Critical patent/NO2575858T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO11790534A 2010-06-05 2011-06-06 NO2575858T3 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35186610P 2010-06-05 2010-06-05
PCT/US2011/039255 WO2011153525A2 (en) 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions

Publications (1)

Publication Number Publication Date
NO2575858T3 true NO2575858T3 (pt) 2018-05-19

Family

ID=45067339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO11790534A NO2575858T3 (pt) 2010-06-05 2011-06-06

Country Status (13)

Country Link
EP (2) EP3318269B1 (pt)
JP (1) JP5904560B2 (pt)
KR (1) KR20130132375A (pt)
CN (2) CN107412729A (pt)
AU (1) AU2011261196B2 (pt)
CA (1) CA2801579C (pt)
DK (1) DK2575858T3 (pt)
ES (1) ES2663096T3 (pt)
HK (1) HK1252916A1 (pt)
NO (1) NO2575858T3 (pt)
PL (1) PL2575858T3 (pt)
PT (1) PT2575858T (pt)
WO (1) WO2011153525A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9139629B2 (en) 2010-06-05 2015-09-22 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
US20110301103A1 (en) 2010-06-05 2011-12-08 Chugh Sumant S Methods of Treatment
CA3207108A1 (en) * 2013-03-15 2014-09-18 Sumant S. CHUGH Methods for treatment of nephrotic syndrome and related conditions
CN106170700A (zh) * 2014-01-20 2016-11-30 玛丽亚·阿黛尔·西尔维亚·丹尼杰奥派德4有限公司 用于狼疮肾炎的治疗性随访中的预测、诊断和监测的体外方法
CN114934021B (zh) * 2022-04-21 2023-08-08 复旦大学附属儿科医院 一种Angptl3敲除的鼠永生化足细胞系及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005825A2 (en) * 1999-07-16 2001-01-25 Hyseq, Inc. Nucleic acid sequences encoding putative angiopoietin proteins
JP2005080508A (ja) * 2003-09-04 2005-03-31 Sankyo Co Ltd 脂質代謝改善剤の試験方法
CN1980686A (zh) * 2004-04-05 2007-06-13 安斯泰来制药有限公司 抗肥胖药
CN101080419B (zh) * 2004-07-20 2014-07-02 健泰科生物技术公司 利用血管生成素样4蛋白的组合物和方法
AU2007227251A1 (en) * 2006-03-20 2007-09-27 Amgen Fremont, Inc. Antibodies directed to angiopoietin-like protein 4 and uses thereof
EP3175859B1 (en) * 2007-05-31 2020-09-23 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services N-acetyl mannosamine for the treatmetn of a kidney-disease

Also Published As

Publication number Publication date
CN107412729A (zh) 2017-12-01
WO2011153525A9 (en) 2012-04-19
ES2663096T3 (es) 2018-04-11
EP2575858A4 (en) 2014-01-01
JP2013528625A (ja) 2013-07-11
CN103140234B (zh) 2016-12-21
EP2575858A2 (en) 2013-04-10
JP5904560B2 (ja) 2016-04-13
EP3318269A1 (en) 2018-05-09
CN103140234A (zh) 2013-06-05
CA2801579C (en) 2021-12-14
EP3318269C0 (en) 2024-03-13
EP3318269B1 (en) 2024-03-13
EP2575858B1 (en) 2017-12-20
AU2011261196A1 (en) 2013-01-10
AU2011261196B2 (en) 2015-05-21
KR20130132375A (ko) 2013-12-04
DK2575858T3 (en) 2018-03-12
PL2575858T3 (pl) 2018-08-31
PT2575858T (pt) 2018-03-22
HK1252916A1 (zh) 2019-06-06
WO2011153525A2 (en) 2011-12-08
CA2801579A1 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
BR112013013385A2 (pt)
BR112013008959A2 (pt)
BR112012031500A2 (pt)
BR112012029986A2 (pt)
BR112012028408A2 (pt)
BR112012026492A2 (pt)
BR112012024897A2 (pt)
BR112012025307A2 (pt)
BR112012026946A2 (pt)
BR112012025482A2 (pt)
BR112013006400A2 (pt)
BR112012031826A2 (pt)
BR112012025577A2 (pt)
BR112012027015A2 (pt)
BR112012025308A2 (pt)
BR112012027945A2 (pt)
BR112012024872A2 (pt)
BR112013010949A2 (pt)
BR112013003284A2 (pt)
BR112013002646A2 (pt)
BR112012026403A2 (pt)
BR112013012726A2 (pt)
BR112013006825A2 (pt)
BR112012028859A2 (pt)
BR112013007728A2 (pt)